ReviewFrontiers in bioengineering and biotechnology2026
Improved healing and tissue regeneration for prevention and treatment of pelvic floor disorders: from reactive treatment to proactive prevention.
Review in Frontiers in bioengineering and biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pelvic floor disorders (PFDs), including pelvic organ prolapse (POP), stress urinary incontinence (SUI), and obstetric fistula, impose a major global health burden. Largely driven by birth-related trauma, they reduce quality of life and can cause physical, psychological, and social consequences. Current surgical and conservative treatments often fail to address underlying tissue damage and impaired healing, contributing to high recurrence; up to 30% of patients require repeat procedures. Tissue engineering and regenerative medicine offer promising alternatives by targeting damaged pelvic tissues and promoting repair and regeneration. Enhanced healing strategies can potentially prevent PFD development by strengthening pelvic floor tissues during critical periods of vulnerability, such as pregnancy and childbirth, while also improving outcomes following injury or surgical intervention. This paradigm shift from reactive treatment to proactive prevention and biological restoration represents a transformative opportunity in PFD management. This review examines the current landscape of tissue regeneration strategies for PFDs. We explore emerging therapeutic approaches within the tissue engineering framework, including biofunctional materials, cell-based therapies, bioactive molecules, molecular interventions, and external stimulations designed to promote native tissue regeneration. This review provides an overview of impaired healing mechanisms in pelvic floor tissues and evaluate how targeted regenerative interventions address these deficiencies. We examine the clinical implications of regenerative strategies in PFD management, including reduced surgical burden, improved outcomes, and preventive interventions. Emphasis is placed on their translational potential from bench to bedside, to inform clinicians and researchers about innovative approaches that may fundamentally transform the prevention and treatment of pelvic floor disorders.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.